The Discounted Cash Flow (DCF) valuation of Integra Lifesciences Holdings Corp (IART) is 15.91 USD. With the latest stock price at 12.75 USD, the upside of Integra Lifesciences Holdings Corp based on DCF is 24.8%.
Based on the latest price of 12.75 USD and our DCF valuation, Integra Lifesciences Holdings Corp (IART) is a buy. buying IART stocks now will result in a potential gain of 24.8%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.1% | 7.5% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 3.14 - 61.77 | 15.91 |
| Upside | -75.4% - 384.5% | 24.8% |